Ciprofloxacin Betaine is a fluoroquinolone antibacterial active pharmaceutical ingredient (API) used in pharmaceutical research, development and manufacturing. It is the free-base, zwitterionic form of ciprofloxacin and is chemically distinct from Ciprofloxacin Hydrochloride.
Ciprofloxacin Betaine is available in different solid-state forms, including hydrated forms. The exact hydrate, assay basis and applicable quality standard should be confirmed through the approved product specification and Certificate of Analysis (COA).
Ciprofloxacin Betaine is relevant to pharmaceutical formulation development, analytical research, antibacterial product manufacturing and process development.
Potential applications include:
Its suitability for any specific dosage form depends on the approved formulation, regulatory requirements and drug-substance specifications.
Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes involved in bacterial DNA replication and related cellular processes. This activity disrupts bacterial DNA function and produces antibacterial effects against susceptible organisms.
Ciprofloxacin is a prescription antibacterial drug. Its use must follow applicable regulatory requirements and antimicrobial stewardship principles.
API procurement and quality evaluation should consider identity, assay, related substances, water content, residual solvents, solid-state form and stability.
Depending on availability and qualification requirements, supporting documentation may include:
Pharmacopoeial compliance, manufacturing certifications and batch-release limits should be stated only when supported by verified documents.
Ciprofloxacin Betaine should be packed in suitable, tightly closed containers that protect the material from moisture, contamination and inappropriate light exposure. Packaging configuration and storage temperature must follow the approved stability data and product label.
Handle the material using appropriate pharmaceutical manufacturing controls, personal protective equipment and dust-management procedures. Prevent uncontrolled environmental release of antibiotic-containing material. This bulk API is not intended for direct patient administration.
What is Ciprofloxacin Betaine?
Ciprofloxacin Betaine is a fluoroquinolone antibacterial drug substance in its free-base or zwitterionic form.
Is Ciprofloxacin Betaine the same as Ciprofloxacin Hydrochloride?
No. Ciprofloxacin Hydrochloride is a hydrochloride salt with different physicochemical characteristics and specifications.
Does Ciprofloxacin Betaine occur as a hydrate?
Yes. Hydrated forms, including the 3.5-hydrate, are documented. The supplied form should be confirmed through product specifications.
Is Ciprofloxacin Betaine IH a pharmacopoeial grade?
The IH designation requires confirmation. Any IP or other pharmacopoeial claim must be supported by the applicable current monograph and approved batch documents.
Is a Certificate of Analysis required?
A batch-specific COA is important for confirming identity, assay, impurities and other quality attributes before pharmaceutical use.
For Ciprofloxacin Betaine API procurement, request information about available solid-state forms, batch specifications, documentation, packaging options and commercial availability. Submit a product enquiry with your required quantity, intended application and quality requirements.
| Parameter | Specification |
|---|---|
| Appearance | Pale-yellowish to light-yellow crystalline |
| Identification | IR and HPLC complaint |
| Assay (HPLC) | 99.0%–101.0% |
| Heavy Metals | NMT 10 ppm |
| Solubility | Sparingly soluble in water |